Home > Insider Trading > Filing (0001567619-21-008995)

Filing Details

Accession Number:: 0001567619-21-008995
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-04 13:00:00
Reporting Period:: 2021-04-30

Accepted Time:: 2021-05-04 16:55:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
722723	Hanger Inc.	HGR	Services-Specialty Outpatient Facilities, Nec (8093)	840904275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1651089	B. Gabrielle Adams	10910 Domain Drive, Suite 300 Austin TX 78758	Vice President Accounting	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-30	20,938	$12.77	80,961	No	4	M	Direct
Common Stock	Disposition	2021-04-30	20,938	$25.03	60,023	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (right to buy)	Disposition	2021-04-30	20,938	$0.00	20,938	$12.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2027-05-19	No	4	M	Direct

Footnotes

The transaction by Ms. Adams was effected automatically upon the satisfaction of certain timing, trading price and other conditions under a trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Ms. Adams entered into this trading plan on March 8, 2021 and additional periodic sales may occur under this plan through the end of 2021 if the conditions of the plan are met.
These shares were sold at a range of sale prices from $25.00 to $25.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Includes (i) unvested restricted shares totaling 4,227 shares of stock from an initial grant of 4,227 shares of restricted stock that begins to vest on March 8, 2022;(ii) unvested restricted shares totaling 3,230 shares of stock from an initial grant of 3,583 shares of restricted stock that begins to vest on March 9, 2021; (iii) unvested restricted shares totaling 3,800 shares of stock from an initial grant of 4,215 shares of restricted stock that begins to vest on March 9, 2021; (iv) unvested restricted shares and fully vested shares totaling 3,095 shares of stock from an initial grant of 3,854 shares of restricted stock made on March 8, 2019; (v) unvested restricted shares and fully vested shares totaling 3,668 shares of stock from an initial grant of 4,567 shares of restricted stock made on March 8, 2019; [continued in next footnote]
(vi) unvested restricted shares and fully vested shares totaling 3,180 shares of stock from an initial grant of 4,435 shares of restricted stock made on March 8, 2019; (vii) unvested restricted shares and fully vested shares totaling 3,997 shares of stock from an initial grant of 5,574 shares of restricted stock made on March 9, 2018; (viii) unvested restricted shares and fully vested shares totaling 5,710 shares of stock from an initial grant of 7,950 shares of restricted stock made on March 8, 2017; [continued in next footnote]
(ix) fully vested shares totaling 2,446 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; (x) unvested restricted shares and fully vested shares totaling 6,233 shares of stock from an initial grant of 7,750 shares of restricted stock made on April 29, 2016; (xi) fully vested shares which total 3,020 shares of stock from an initial grant of 3,305 shares of restricted stock made on November 10, 2015; [continued in next footnote]
(xii) fully vested shares which total 2,037 shares of stock from an initial grant of 2,229 shares of restricted stock made on September 8, 2015; and (xiii) fully vested shares which total 3,818 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015.
Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.